Galantamine Normon 24 mg prolonged-release hard capsules EFG

Spain
Brand name Galantamine Normon 24 mg prolonged-release hard capsules EFG
Form capsules, hard, prolonged release
Active substance / Dosage
Prescription type Hospital Diagnosis
Registration number 78444
Galantamine Normon 24 mg prolonged-release hard capsules EFG capsules, hard, prolonged release

Patient Information Leaflet

Introduction

Package Leaflet: Information for the patient

Galantamina Normon 24 mg prolonged-release hard capsules EFG

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents:

  1. What Galantamina Normon is and what it is used for.
  2. What you need to know before taking Galantamina Normon.
  3. How to take Galantamina Normon.
  4. Possible adverse effects.
  5. How to store Galantamina Normon.
  6. Contents of the pack and other information.

1. What Galantamina Normon is and what it is used for

Galantamina Normon is an antidementia medicine used to treat the symptoms of mild to moderate Alzheimer-type dementia, a condition in which brain function is impaired.

Symptoms of Alzheimer's disease include memory loss, increased confusion, and behavioral changes. As a result, it becomes increasingly difficult to carry out routine daily activities.

These symptoms are believed to be due to a lack of acetylcholine, a substance responsible for transmitting messages between brain cells. Galantamine increases the amount of acetylcholine in the brain, thereby potentially improving the symptoms of the disease.

The capsules are in "prolonged-release" form. This means they release the medicine gradually.

2. What you need to know before taking Galantamina Normon

Do not take Galantamina Normon

  • If you are allergic to galantamine or to any of the other ingredients of this medicine (listed in section 6).
  • If you have severe liver and/or kidney disease.

Warnings and precautions

Talk to your doctor or pharmacist before starting Galantamina Normon.

Galantamine should be used for Alzheimer's disease and not for other types of memory loss or confusion.

Medicines are not always suitable for everyone. Before starting treatment with galantamine, your doctor should know if you have or have had any of the following conditions:

  • liver or kidney problems,
  • a heart disorder (for example, angina, heart attack, heart failure, slow or irregular pulse, prolonged QTc interval),
  • an electrolyte imbalance (for example, high or low potassium levels in the blood),
  • peptic ulcer (stomach),
  • acute abdominal pain,
  • a disorder of the nervous system (such as epilepsy or Parkinson's disease),
  • a respiratory disease or infection affecting breathing (such as asthma, obstructive lung disease, or pneumonia),
  • if you have recently had surgery on the intestine or bladder,
  • if you have difficulty passing urine.

If you are due to undergo surgery under general anaesthesia, tell your doctor that you are taking galantamine.

Your doctor will then decide whether galantamine treatment is suitable for you and whether your dose needs to be adjusted.

Taking Galantamina Normon with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or might need to use any other medicines.

Galantamine should not be taken together with medicines that work in the same way. These include:

  • donepezil or rivastigmine (for Alzheimer's disease),
  • ambenonium, neostigmine, or pyridostigmine (for severe muscle weakness),
  • pilocarpine (for dry eyes or mouth) when taken by mouth.

Some medicines may alter the effects of galantamine, or galantamine may reduce the effectiveness of other medicines when taken together. These include:

  • paroxetine or fluoxetine (antidepressants),
  • quinidine (for heart rhythm disorders),
  • ketoconazole (antifungal),
  • erythromycin (antibiotic),
  • ritonavir (antiviral protease inhibitor for HIV),
  • medicines that affect the QTc interval.

Your doctor may prescribe a lower dose of Galantamina Normon if you are also taking any of the medicines listed above.

Some medicines may increase the number of side effects caused by galantamine. These include:

  • non-steroidal anti-inflammatory analgesics (for example, ibuprofen), which may increase the risk of ulcers,
  • medicines for certain heart problems or high blood pressure (for example, digoxin, amiodarone, atropine, beta-blockers, or calcium channel blockers). If you are taking medicines for an irregular heartbeat, your doctor may consider it necessary to perform an electrocardiogram (ECG).

If you are due to undergo surgery under general anaesthesia, tell your doctor that you are taking galantamine.

Consult your doctor or pharmacist if you have any doubts.

Taking Galantamina Normon with food and drink

It is recommended to take galantamine with food.

During treatment with galantamine, you should drink enough fluids to stay hydrated (see section 3).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

You should not breastfeed while taking Galantamina Normon.

Driving and using machines

Galantamine may cause dizziness or drowsiness, especially at the beginning of treatment or when the dose is increased. If you experience these effects, you should not drive or operate machinery.

3. How to take Galantamina Normon

Follow exactly the instructions for administering this medicine as given by your doctor. If in doubt, consult your doctor or pharmacist again.

If you are currently taking galantamine tablets or oral solution and your doctor has told you that you will be switching to Galantamina Normon prolonged-release capsules, please read carefully the instructions at the end of this section.

How to take your Galantamina Normon capsules

Galantamina Normon capsules must be swallowed whole. DO NOT chew or crush them. IF you have difficulty swallowing the capsules, you may empty the capsule and swallow the contents whole – (DO NOT chew or crush the capsule contents).

Galantamina Normon should be taken in the morning, with water or other liquids and preferably with food.

Galantamina Normon prolonged-release capsules are available in three strengths: 8 mg, 16 mg, and 24 mg.

Treatment with galantamine starts at a low dose. Your doctor may gradually increase the dose (strength) of galantamine you are taking until the most appropriate dose for you is reached.

  1. Treatment starts with one 8 mg capsule once daily. After 4 weeks of treatment, the dose is increased.
  2. You will then take one 16 mg capsule once daily. After at least another 4 weeks of treatment, your doctor may decide to increase the dose again.
  3. You will then take one 24 mg capsule once daily.

Your doctor will explain which dose to start with and when to increase it. If you feel that the effect of galantamine is too strong or too weak, inform your doctor or pharmacist.

Your doctor needs to see you regularly to check how well this medicine is working for you and to discuss how you are feeling. Your doctor will also monitor your weight regularly during treatment with galantamine.

Liver or kidney disease

  • If you have mild liver or kidney disease, treatment starts with one 8 mg capsule once daily in the morning.
  • If you have moderate liver or kidney disease, treatment starts with one 8 mg capsule every other morning. After one week, begin taking the 8 mg capsule once daily in the morning. Do not take more than 16 mg once daily.
  • If you have severe liver or kidney disease, do not take galantamine.

Use in children and adolescents

Galantamine is not recommended for use in children and adolescents under 18 years of age.

If you take more Galantamina Normon than you should

If you have taken more galantamine than you should, contact your doctor or go immediately to the nearest hospital, or call the Spanish Toxicology Information Service at telephone number 91 562 04 20, indicating the medicine and the amount taken. Bring the pack with any remaining capsules. Signs and symptoms of overdose may include, among others: severe nausea, vomiting, muscle weakness, slow heartbeat, seizures, and loss of consciousness.

If you forget to take Galantamina Normon

If you forget to take a dose, skip that dose and continue your treatment as usual with the next scheduled dose.

If you miss more than one dose, you should consult your doctor.

Do not take a double dose to make up for missed doses.

If you stop taking Galantamina Normon

Consult your doctor before stopping treatment with galantamine. It is important to continue taking this medicine to treat your condition.

How to switch from galantamine tablets or oral solution to Galantamina Normon prolonged-release capsules

If you are currently taking galantamine tablets or oral solution, your doctor may decide to switch you to Galantamina Normon prolonged-release capsules.

  • Take your last dose of galantamine tablets or oral solution in the evening.
  • The next morning, take your first dose of Galantamina Normon prolonged-release capsules.

Do NOT take more than one capsule per day. While taking Galantamina Normon capsules once daily, DO NOT take galantamine tablets or oral solution.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, Galantamine Normon may produce adverse effects, although not everyone experiences them. Some of these effects may be due to the disease itself.

Stop taking your medicine and consult your doctor immediately if you experience:

  • Heart problems including changes in heartbeat (slow or irregular).
  • Palpitations (pounding heartbeat).
  • Other disturbances such as fainting.
  • An allergic reaction. Signs may include rash, difficulty swallowing or breathing, or swelling of the lips, face, throat, or tongue.

Adverse effects include:

Very common: may affect more than 1 in 10 people

  • Feeling unwell with nausea and/or vomiting. If these undesirable effects occur, they are mainly experienced at the beginning of treatment or when the dose is increased. They usually disappear gradually as the body adapts to the treatment and generally pass after a few days. If you experience these effects, your doctor may recommend drinking more fluids and, if necessary, may prescribe a medicine to help you feel better.

Common: may affect up to 1 in 10 people

  • Weight loss.
  • Loss of appetite.
  • Decreased appetite.
  • Slow heartbeat.
  • Feeling of weakness.
  • Dizziness.
  • Tremors.
  • Headache.
  • Drowsiness.
  • Abnormal tiredness.
  • Abdominal pain or discomfort.
  • Diarrhea.
  • Indigestion (with a feeling of acidity).
  • Increased sweating.
  • Muscle cramps.
  • Falls.
  • Increased blood pressure.
  • Feeling of weakness.
  • General feeling of being unwell.
  • Seeing, feeling, or hearing things that are not real (hallucinations).
  • Feeling of sadness (depression).

Uncommon: may affect up to 1 in 100 people

  • Increased liver enzymes in blood (laboratory test results show whether your liver is working properly).
  • Possible abnormal heartbeat.
  • Alteration in the heart's impulse conduction mechanism.
  • Sensation of abnormal heartbeats (palpitations).
  • Tingling, pricking, or numbness of the skin.
  • Change in taste sensation.
  • Excessive sleepiness.
  • Blurred vision.
  • Ringing or buzzing in the ears (tinnitus).
  • Feeling the need to vomit.
  • Muscle weakness.
  • Excessive loss of body water.
  • Decreased blood pressure.
  • Flushing of the face.
  • Allergic reaction.

Rare: may affect up to 1 in 1,000 people

  • Inflammation of the liver (hepatitis).

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicinal Products: www.notificaRAM.es.

By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Galantamine Normon

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use Galantamine Normon after the expiry date stated on the packaging after "EXP". The expiry date refers to the last day of the month indicated.

Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of unused medicines and their containers. This will help protect the environment.

6. Contents of the pack and other information

Composition of GalantaminaNormon

The active substance is galantamine hydrobromide. Each prolonged-release capsule contains 24 mg of galantamine (as hydrobromide).

The other components (excipients) of the tablets are: calcium hydrogen phosphate dihydrate, ethylcellulose, magnesium stearate, hypromellose, and triethyl citrate.

The other components (excipients) of the capsules are: gelatin, titanium dioxide, yellow iron oxide, and red iron oxide.

Appearance of the medicine and contents of the pack

Galantamina Normon is presented as hard caramel-colored capsules containing three white, round prolonged-release tablets.

Each pack contains 28 prolonged-release hard capsules.

Marketing Authorization Holder and Manufacturer

LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)

OTHER PRESENTATIONS

Galantamina Normon 8 mg prolonged-release hard capsules EFG.

Galantamina Normon 16 mg prolonged-release hard capsules EFG.

Galantamina Normon 4 mg/ml oral solution EFG.

Date of the most recent review of this leaflet: February 2021

Up-to-date detailed information about this medicinal product is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) http://www.aemps.gob.es/